FERRER MEDICAL INNOVATIONS LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2020-01-01
- Employees
- 11
- Market Cap
- -
Chlorpheniramine Nasal Spray to Accelerate COVID-19 Clinical Recovery in an Outpatient Setting: ACCROS-III
Phase 2
Completed
- Conditions
- COVID-19COVID-19 PandemicCoronavirus InfectionsCoronavirus Disease 2019Symptoms and Signs
- Interventions
- Combination Product: Chlorpheniramine Maleate 0.4% Nasal SprayCombination Product: Placebo
- First Posted Date
- 2023-06-02
- Last Posted Date
- 2023-06-02
- Lead Sponsor
- Dr. Ferrer BioPharma
- Target Recruit Count
- 157
- Registration Number
- NCT05886829
- Locations
- ðŸ‡ðŸ‡³
Hospital CEMESA, Cortés, San Pedro Sula, Honduras
Accelerating COVID-19 Clinical Recovery in the Outpatient Setting: Retrospective Analysis
- Conditions
- COVID-19 PandemicCOVID-19 Respiratory InfectionSARS-CoV-2 Acute Respiratory DiseaseCOVID-19SARS CoV 2 Infection
- Interventions
- Drug: ClorNovir® (Chlorpheniramine) 0.4% Nasal Spray
- First Posted Date
- 2022-08-30
- Last Posted Date
- 2022-08-30
- Lead Sponsor
- Dr. Ferrer BioPharma
- Target Recruit Count
- 1000
- Registration Number
- NCT05520944
- Locations
- 🇩🇴
Clinica Union Medica, Santiago De Los Caballeros, Dominican Republic
Chlorpheniramine Nasal Spray to Accelerate COVID-19 Clinical Recovery in an Outpatient Setting: ACCROS-I
Phase 2
Completed
- Conditions
- Symptoms and SignsCoronavirus Disease 2019COVID-19COVID-19 PandemicCoronavirus Infections
- Interventions
- Combination Product: Chlorpheniramine Maleate 1% Nasal SprayCombination Product: Placebo
- First Posted Date
- 2022-07-08
- Last Posted Date
- 2023-03-23
- Lead Sponsor
- Dr. Ferrer BioPharma
- Target Recruit Count
- 101
- Registration Number
- NCT05449405
- Locations
- ðŸ‡ðŸ‡³
Hospital CEMESA, Cortés, San Pedro Sula, Honduras
© Copyright 2025. All Rights Reserved by MedPath